10-K Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 FY 2016

Filing Information

Form Type	10-K
Accession Number	`0001144204-17-014602`
Period End Date	20161231
Filing Date	20170315
Fiscal Year	2016
Fiscal Period	FY
XBRL Instance	bpth-20161231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 81 Cash Flow Statement 67 Stockholders Equity 28

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$8.85M	USD	Point-in-time
Cash	`Cash`	$9.38M	USD	Point-in-time
Cash	`Cash`	$3.55M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$13.86M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$376.00K	USD	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$560.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$179.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$902.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.59M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$10.65M	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	95.65M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	89.76M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	95.65M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$123.00K	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$708.00K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	89.76M	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$51.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$94.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$614.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$72.00K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.41M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.57M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$929.00K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$1.09M	USD	Point-in-time
Total Assets	`Assets`	$10.76M	USD	Point-in-time
Total Assets	`Assets`	$12.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$54.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.00K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$969.00K	USD	Point-in-time
Accrued expense	`AccruedLiabilitiesCurrent`	$883.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	-	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.05M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$937.00K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.91M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$937.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.96M	USD	Point-in-time
Preferred stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value, 200,000,000 shares authorized 95,645,224 and 89,762,872 shares issued and outstanding as of 12/31/16 and 12/31/15, respectively	`CommonStockValue`	$96.00K	USD	Point-in-time
Common stock, $.001 par value, 200,000,000 shares authorized 95,645,224 and 89,762,872 shares issued and outstanding as of 12/31/16 and 12/31/15, respectively	`CommonStockValue`	$90.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$35.11M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$40.28M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.13M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-25.38M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$14.92M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$9.82M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$4.78M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.24M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$12.20M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$10.76M	USD	Point-in-time

Income Statement 81 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	$13.00K	USD	Annual
Revenue	`Revenues`	$13.00K	USD	1 Quarter
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	Annual
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.63M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.47M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.02M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$3.01M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.71M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.46M	USD	Annual
Total operating expense	`OperatingExpenses`	$5.49M	USD	Annual
Total operating expense	`OperatingExpenses`	$1.46M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$8.49M	USD	Annual
Total operating expense	`OperatingExpenses`	$1.94M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.38M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$4.54M	USD	Annual
Total operating expense	`OperatingExpenses`	$1.13M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$2.99M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.68M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.51M	USD	1 Quarter
Total operating expense	`OperatingExpenses`	$1.87M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.94M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.51M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.87M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.46M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.38M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-2.99M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-4.54M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-8.47M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-1.13M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.67M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-5.49M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.71M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Interest income	`InvestmentIncomeInterest`	$18.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$23.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$12.00K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$5.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.73M	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$18.00K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$1.42M	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$5.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$4.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$23.00K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$4.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$297.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.94M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.37M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	Annual
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.28M	shares	Annual
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	Annual
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	92.70M	shares	Annual

Cash Flow Statement 67 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.94M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.37M	USD	1 Quarter
Amortization	`AdjustmentForAmortization`	$161.00K	USD	Annual
Amortization	`AdjustmentForAmortization`	$161.00K	USD	Annual
Amortization	`AdjustmentForAmortization`	$161.00K	USD	Annual
Depreciation	`Depreciation`	$43.00K	USD	Annual
Depreciation	`Depreciation`	$41.00K	USD	Annual
Depreciation	`Depreciation`	$10.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$784.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$404.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$369.00K	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-1.71M	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$104.00K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$405.00K	USD	Annual
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$-184.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$36.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$79.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$723.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$267.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$375.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-146.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$12.00K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-8.15M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.82M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-5.00M	USD	Annual
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$123.00K	USD	Annual
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$338.00K	USD	Annual
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-338.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-123.00K	USD	Annual
Net proceeds from sale of common stock and warrants	`ProceedsFromIssuanceOfCommonStockAndWarrants`	-	USD	Annual
Net proceeds from sale of common stock and warrants	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$13.81M	USD	Annual
Net proceeds from sale of common stock and warrants	`ProceedsFromIssuanceOfCommonStockAndWarrants`	$9.01M	USD	Annual
Net proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	$435.00K	USD	Annual
Net proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Net proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$14.25M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$9.01M	USD	Annual
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$10.31M	USD	Annual
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$-5.00M	USD	Annual
Net increase (decrease) in cash	`CashPeriodIncreaseDecrease`	$521.00K	USD	Annual
Cash, beginning of period	`Cash`	$8.85M	USD	Point-in-time
Cash, beginning of period	`Cash`	$9.38M	USD	Point-in-time
Cash, beginning of period	`Cash`	$3.55M	USD	Point-in-time
Cash, beginning of period	`Cash`	$13.86M	USD	Point-in-time
Cash, end of period	`Cash`	$8.85M	USD	Point-in-time
Cash, end of period	`Cash`	$9.38M	USD	Point-in-time
Cash, end of period	`Cash`	$3.55M	USD	Point-in-time
Cash, end of period	`Cash`	$13.86M	USD	Point-in-time
Capital expenditures included in accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	$247.00K	USD	Annual
Capital expenditures included in accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	Annual
Capital expenditures included in accrued expense	`CapitalExpendituresIncurredButNotYetPaid`	-	USD	Annual

Stockholders Equity 28 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$14.92M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$9.82M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$4.78M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$8.24M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$4.39M	USD	Annual
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$13.81M	USD	Annual
Issuance of common stock, net of fees (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	5.00M	shares	Point-in-time
Issuance of common stock, net of fees (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	5.00M	shares	Point-in-time
Issuance of common stock, net of fees (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	5.88M	shares	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$436.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$368.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$784.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalOther`	$404.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-1.94M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.52M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.75M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.47M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.87M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.46M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.37M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$14.92M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$9.82M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$4.78M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$8.24M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.